Medication Costs and Health Care Use in Child Asthma

Published Online: Wednesday, April 18, 2012
Follow Pharmacy_Times:
In this video, Dana Goldman, PhD, Director of the Schaeffer Center for Health Policy and Economics at the University of Southern California, discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children’s asthma medication. Using insurance claims, the study authors identified 8800 children being treated with long-term asthma medication and then analyzed data about them to establish how often patients filled prescriptions for daily medications and estimated actual medication use. The study authors then compared use of other medical services, including hospital stays and emergency room visits, to determine whether those services were also affected.

Related Articles
Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients’ treatment preferences when chronic disease is present.
AstraZeneca and Abbott are teaming up to develop companion diagnostic blood tests that will identify patients with severe asthma who would benefit most from biological tralokinumab therapy.
Asthma controller medications are underused in neighborhoods with high rates of asthma-related emergency room use and hospitalization, but pharmacists are in a prime position to correct it.
The FDA today expanded the indication of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$